Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers
Authors
Keywords
-
Journal
Clinical Proteomics
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-24
DOI
10.1186/s12014-023-09432-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma
- (2019) Anjali Arora et al. Scientific Reports
- Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
- (2019) Saenz-Antoñanzas et al. Cancers
- Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
- (2019) Silantyev et al. Cells
- Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers
- (2018) Jonghwa Jin et al. CLINICAL BIOCHEMISTRY
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics
- (2018) Eisuke Miyauchi et al. PLoS One
- Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma
- (2018) Damir Nizamutdinov et al. World Neurosurgery
- Liquid biopsy for brain tumors
- (2017) Ganesh M. Shankar et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Management and potentialities of primary cancer cultures in preclinical and translational studies
- (2017) Giacomo Miserocchi et al. Journal of Translational Medicine
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Proteomic profiling of human plasma for cancer biomarker discovery
- (2016) Zhao Huang et al. PROTEOMICS
- Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics
- (2016) Jonghwa Jin et al. Journal of Diabetes Research
- Label-Free Quantitative Proteomics and N-terminal Analysis of Human Metastatic Lung Cancer Cells
- (2014) Hophil Min et al. MOLECULES AND CELLS
- The human secretome atlas initiative: Implications in health and disease conditions
- (2013) Kristy J. Brown et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Investigation of serum proteome alterations in human glioblastoma multiforme
- (2012) Kishore Gollapalli et al. PROTEOMICS
- Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide
- (2011) Michael C Dobelbower et al. Journal of Medical Imaging and Radiation Oncology
- Proteomics of gliomas: Initial biomarker discovery and evolution of technology
- (2011) J. Kalinina et al. NEURO-ONCOLOGY
- Pattern of Failure After Limited Margin Radiotherapy and Temozolomide for Glioblastoma
- (2010) Mark W. McDonald et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiographic patterns of relapse in glioblastoma
- (2010) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide
- (2010) Giuseppe Minniti et al. RADIOTHERAPY AND ONCOLOGY
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started